메뉴 건너뛰기




Volumn 87, Issue 3, 2002, Pages 233-234

Thalidomide in multiple myeloma: State of art

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CYTOTOXIC AGENT; DEXAMETHASONE; IMMUNOMODULATING AGENT; INTERLEUKIN 6; THALIDOMIDE; TUMOR NECROSIS FACTOR ALPHA;

EID: 0036196843     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial
Times cited : (9)

References (23)
  • 15
    • 79960970619 scopus 로고    scopus 로고
    • Risk factors for deep vein thrombosis in a large group of myeloma patients treated with thalidomide: The Arkansas experience
    • abstract
    • (2001) Blood , vol.98 , pp. 161
    • Zangari, M.1    Siegel, E.2    Anaissie, E.3
  • 16
    • 0033546823 scopus 로고    scopus 로고
    • Low-dose thalidomide seems to be effective in multiple myeloma
    • (1999) Lancet , vol.354 , pp. 925
    • Larkin, M.1
  • 23
    • 0003234481 scopus 로고    scopus 로고
    • abstract
    • (2001) Blood , vol.98 , pp. 775


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.